CareDx Inc (CareDx) is a leading precision medicine company that focuses on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for kidney transplant patients. The company’s product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. CareDx offers testing services including diagnostic surveillance testing services, lab products services, HLA typing service and AlloSeq cfDNA service. It also provides digital transplant solutions. The company operates in the US, Sweden and Australia. CareDx is headquartered in South San Francisco, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CareDx Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- CareDx Inc Company Overview
- CareDx Inc Company Snapshot
- CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview
- CareDx Inc - Pipeline Analysis Overview
- CareDx Inc - Key Facts
- CareDx Inc - Major Products and Services
- CareDx Inc Pipeline Products by Development Stage
- CareDx Inc Ongoing Clinical Trials by Trial Status
- CareDx Inc Pipeline Products Overview
- AiCav
- AiCav Product Overview
- AiKidney
- AiKidney Product Overview
- AlloHeme - Hematologic Malignancies
- AlloHeme - Hematologic Malignancies Product Overview
- AlloHeme Liver
- AlloHeme Liver Product Overview
- AlloHeme Liver Clinical Trial
- AlloID
- AlloID Product Overview
- AlloMap Liver
- AlloMap Liver Product Overview
- AlloSeq BMT
- AlloSeq BMT Product Overview
- AlloSure - BKV-Associated Nephropathy (BKVAN)
- AlloSure - BKV-Associated Nephropathy (BKVAN) Product Overview
- AlloSure Liver
- AlloSure Liver Product Overview
- Clinical Decision Support Tool
- Clinical Decision Support Tool Product Overview
- Diagnostic Test - Crohn's Disease
- Diagnostic Test - Crohn's Disease Product Overview
- Diagnostic Test - Multiple Sclerosis
- Diagnostic Test - Multiple Sclerosis Product Overview
- Diagnostic Test - Rheumatoid Arthritis
- Diagnostic Test - Rheumatoid Arthritis Product Overview
- Diagnostic Test - Sjogren's Syndrome
- Diagnostic Test - Sjogren's Syndrome Product Overview
- Diagnostic Test - Systemic Lupus Erythematosus
- Diagnostic Test - Systemic Lupus Erythematosus Product Overview
- HistoMap
- HistoMap Product Overview
- HistoMap Clinical Trial
- HistoMap Liver
- HistoMap Liver Product Overview
- Post Transplant Management-Lung Transplant
- Post Transplant Management-Lung Transplant Product Overview
- UroMap
- UroMap Product Overview
- CareDx Inc - Key Competitors
- CareDx Inc - Key Employees
- CareDx Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- CareDx Inc, Recent Developments
- Apr 29, 2025: CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting
- Apr 24, 2025: CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting
- Mar 11, 2025: Caredx Launches Two Expanded Indications for Allosure Testing Services
- Feb 20, 2025: CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
- Feb 13, 2025: Caredx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of Alloheme in Early Relapse Detection for Hematologic Malignancies
- Jan 13, 2025: CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results
- Nov 04, 2024: CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
- Sep 12, 2024: CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer
- Aug 16, 2024: CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing
- May 16, 2024: Landmark Study Shows CareDx’s Heartcare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview
- CareDx Inc Pipeline Products by Equipment Type
- CareDx Inc Pipeline Products by Indication
- CareDx Inc Ongoing Clinical Trials by Trial Status
- CareDx Inc, Key Facts
- CareDx Inc, Major Products and Services
- CareDx Inc Number of Pipeline Products by Development Stage
- CareDx Inc Pipeline Products Summary by Development Stage
- CareDx Inc Ongoing Clinical Trials by Trial Status
- CareDx Inc Ongoing Clinical Trials Summary
- AiCav - Product Status
- AiCav - Product Description
- AiKidney - Product Status
- AiKidney - Product Description
- AlloHeme - Hematologic Malignancies - Product Status
- AlloHeme - Hematologic Malignancies - Product Description
- AlloHeme Liver - Product Status
- AlloHeme Liver - Product Description
- AlloHeme Liver - Assessment of Chimerism and Relapse Post Bone Marrow/HCT Transplant Using AlloHeme Test (ACROBAT)
- AlloID - Product Status
- AlloID - Product Description
- AlloMap Liver - Product Status
- AlloMap Liver - Product Description
- AlloSeq BMT - Product Status
- AlloSeq BMT - Product Description
- AlloSure - BKV-Associated Nephropathy (BKVAN) - Product Status
- AlloSure - BKV-Associated Nephropathy (BKVAN) - Product Description
- AlloSure Liver - Product Status
- AlloSure Liver - Product Description
- Clinical Decision Support Tool - Product Status
- Clinical Decision Support Tool - Product Description
- Diagnostic Test - Crohn's Disease - Product Status
- Diagnostic Test - Crohn's Disease - Product Description
- Diagnostic Test - Multiple Sclerosis - Product Status
- Diagnostic Test - Multiple Sclerosis - Product Description
- Diagnostic Test - Rheumatoid Arthritis - Product Status
- Diagnostic Test - Rheumatoid Arthritis - Product Description
- Diagnostic Test - Sjogren's Syndrome - Product Status
- Diagnostic Test - Sjogren's Syndrome - Product Description
- Diagnostic Test - Systemic Lupus Erythematosus - Product Status
- Diagnostic Test - Systemic Lupus Erythematosus - Product Description
- HistoMap - Product Status
- HistoMap - Product Description
- HistoMap - AlloSure Lung Assessment and Metagenomics Outcomes Study
- HistoMap Liver - Product Status
- HistoMap Liver - Product Description
- Post Transplant Management-Lung Transplant - Product Status
- Post Transplant Management-Lung Transplant - Product Description
- UroMap - Product Status
- UroMap - Product Description
- CareDx Inc, Key Employees
- CareDx Inc, Other Locations
- CareDx Inc, Subsidiaries
- Glossary
- CareDx Inc Pipeline Products by Equipment Type
- CareDx Inc Pipeline Products by Development Stage
- CareDx Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Qiagen NV
- Eurofins Viracor Inc
- Thermo Fisher Scientific Inc
- Omixon Ltd
- Natera Inc
- Immucor Inc
- Genome Diagnostics BV
